UK research campus expands; FDA clears NGS test for tumors; Orphazyme raises €80 million IPO
→ One of the leading bioscience hubs for R&D in the UK, Babraham Research Campus, got the OK from city planners to add two new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
